Overview

Abobotulinumtoxina Efficacy in Post-Traumatic Headache

Status:
Completed
Trial end date:
2017-02-02
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of abobotulinumtoxina on Veterans with post-traumatic headache
Phase:
Phase 4
Details
Lead Sponsor:
VA Greater Los Angeles Healthcare System
Collaborator:
Ipsen
Treatments:
abobotulinumtoxinA
Botulinum Toxins, Type A